SNN Stock Analysis: Buy, Sell, or Hold?
SNN - Smith & Nephew plc
$31.08
0.38 (1.24%)
▲
5d:
+1.73%
30d:
+0.58%
90d:
-7.17%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 04, 2026
20d
Get Alerted When SNN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SNN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SNN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$53.06
Based on 7.6% avg growth
INTRINSIC VALUE TODAY
$32.94
5.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNN is currently trading at $31.08, which is considered extended relative to its 30-day fair value range of $29.68 to $30.87. From a valuation perspective, the stock is trading at a discount (Forward PE: 13.6) compared to its historical average (16.1). Remarkably, the market is currently pricing in an annual earnings decline of 5.4% over the next few years. This pessimistic expectation contrasts with the company's recent 70.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SNN is in a strong downtrend. The price is approaching resistance at $31.27. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SNN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNN is in a strong downtrend. The price is approaching resistance at $31.27. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SNN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$29.68 -
$30.87
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($34.07)
Trading Range Analysis
30-Day Trading Range
$29.68 -
$30.87
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$28.56
Resistance Level
$31.27
Current Trend
Strong Downtrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.61
Wall Street Target
$34.07
(+9.6%)
Revenue Growth (YoY)
7.4%
Earnings Growth (YoY)
70.4%
Profit Margin
10.1%
Valuation Discount vs History
-5.4% cheaper
PE vs Historical
13.6 vs 16.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.4%
(market-implied from PE analysis)
1-Year Target
$29.40
(-5%)
2-Year Target
$27.81
(-11%)
3-Year Target
$26.31
(-15%)
3-Yr Target (if PE normalizes)
(PE: 14→16)
$31.11
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 11.3%)
$68.60
(+121%)
Base:
(SPY PE: 13.6, Growth: 11.3%)
$42.88
(+38%)
Bear:
(PE: 11.6, Growth: 11.3%)
$36.45
(+17%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 21.47 | Current EPS (TTM): $1.43
Bull Case
$53.91
(+74%)
Analyst growth 59.6%, PE expands to 23.6
Base Case
$49.01
(+58%)
Market implied 59.6%, PE stable at 21.5
Bear Case
$20.88
(-33%)
Severe decline -20.0%, PE contracts to 18.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.6 to 16.1
Stabilization Target:
$36.75
(+18.3%)
PE Expansion Potential:
+18.3%
Share & Embed Analysis
Last updated: July 14, 2026 6:14 AM ET
Data refreshes hourly during market hours. Next update: 7:14 AM
Data refreshes hourly during market hours. Next update: 7:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 67 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 57 HOLD |
